{"id":2863,"date":"2021-09-16T11:47:00","date_gmt":"2021-09-16T09:47:00","guid":{"rendered":"https:\/\/oxfam.symbiotisk.net\/en\/?post_type=pressemeddelelser&#038;p=2863"},"modified":"2025-07-16T11:49:48","modified_gmt":"2025-07-16T09:49:48","slug":"medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner","status":"publish","type":"pressemeddelelser","link":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/","title":{"rendered":"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner"},"content":{"rendered":"\n<div class=\"wp-block-group is-vertical is-content-justification-stretch is-layout-flex wp-container-core-group-is-layout-92f16597 wp-block-group-is-layout-flex\"><h1 class=\"wp-block-post-title\">Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner<\/h1>\n\n\n<div class=\"wp-block-group has-normal-font-size is-vertical is-layout-flex wp-container-core-group-is-layout-4b827052 wp-block-group-is-layout-flex\"><div style=\"font-style:normal;font-weight:700;\" class=\"has-link-color wp-elements-fa7dab4be3bbf058023c896d023e2439 wp-block-post-date has-text-color has-dark-green-color has-normal-font-size\"><time datetime=\"2021-09-16T11:47:00+02:00\">16.09.2021<\/time><\/div><\/div>\n<\/div>\n\n\n\n\n\n<p>Moderna og Pfizer\/BioNTech har en overnormal profit p\u00e5 op mod 69 pct. p\u00e5 salget af Covid-19-vacciner, viser en ny opg\u00f8relse fra People\u00b4s Vaccine Alliance og Oxfam. Det skyldes blandt andet monopoler, patentbeskyttelse og overpriser.<\/p>\n\n\n\n<p>Medicinalvirksomhederne Moderna, Pfizer og BioNtech havde til sammen en indt\u00e6gt p\u00e5 mere end 26 mia. dollars i f\u00f8rste halvdel af 2021. St\u00f8rstedelen af indt\u00e6gterne stammer fra salget af de nye mRNA-Covid19-vacciner.<\/p>\n\n\n\n<p>90 pct. af salget af Covid-19-vaccinerne fra Pfizer\/BioNtech og Moderna er imidlertid udelukkende solgt til de rige lande, og det er samtidig sket til en betydelig overpris, viser opg\u00f8relsen. Kun 0,5 pct. af Pfizers vaccinesalg er g\u00e5et til de fattige lande.<\/p>\n\n\n\n<p>\u201dDet er fuldst\u00e6ndig sk\u00e6vt, at medicinalindustriens \u00f8konomiske interesser og patenter bliver beskyttet p\u00e5 bekostning af menneskeliv. Kun 1,9 pct. af befolkningen i lavindkomstlandene har f\u00e5et f\u00f8rste vaccinestik, mens de rige lande har hamstret til flere gange deres befolkning. <\/p>\n\n\n\n<p>Vi er n\u00f8dt til at sikre, at alle kan f\u00e5 lige adgang til vaccinerne, og at vi s\u00e6tter menneskeliv over profitter,\u201d siger Trine Pertou Mach, politisk chef i Oxfam\u00a0Danmark.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">EU og Danmark blokerer stadig for, at udviklingslande kan producere vacciner<\/h2>\n\n\n\n<p>Over 100 lande \u2013 herunder USA &#8211; har allerede bakket op om et forslag i WTO om midlertidig suspension af patenter, s\u00e5 flere lande kan f\u00e5 mulighed for at producere vacciner. Men en r\u00e6kke rige lande som EU og Danmark blokerer for forslaget. Imens har befolkningen i mange fattige lande endnu ikke f\u00e5et f\u00f8rste stik.<\/p>\n\n\n\n<p>\u201dMange lande rundt om i verden har kapaciteten til at producere vacciner, men vaccinemonopolerne forhindrer lavindkomstlande i at komme i gang. At lade pandemien forts\u00e6tte er en politisk beslutning, der har store konsekvenser nu og i fremtiden. <\/p>\n\n\n\n<p>Vi har vaccinerne, vi har viden, vi har teknologien. Beskyttelsen af medicinalindustriens egne interesser f\u00e5r lige nu lov til at f\u00e5 forrang for lige adgang til vacciner,\u201d siger Trine Pertou Mach, politisk chef i Oxfam\u00a0Danmark.<\/p>\n\n\n\n<p>If\u00f8lge en analyse foretaget af forskere fra Imperial College har de tre medicinalselskaber ogs\u00e5 opkr\u00e6vet en markant overpris. Deres analyse viser, at vaccinerne kan produceres for omkring 1,2 dollars per dosis, men salgsprisen har v\u00e6ret op til 24 gange h\u00f8jere. Og s\u00e5 sent som i forrige uge valgte selskaberne endda at h\u00e6ve prisen p\u00e5 vaccinerne yderligere.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Betaler meget lidt i skat<\/h3>\n\n\n\n<p>Medicinalselskaberne har modtaget over 100 mia. dollars i offentlige midler fra USA, Tyskland og andre lande til udvikling af vaccinerne. P\u00e5 trods af det har Moderna og Pfizer kun betalt meget lidt i skat, viser analysen fra People\u00b4s Vaccine Alliance. <\/p>\n\n\n\n<p>I f\u00f8rste halvdel af 2021 betalte Moderna en selskabsskat p\u00e5 7 pct. i USA, mens Pfizer betalte 15 pct. Det er langt under den almindelige amerikanske selskabsskat p\u00e5 21 pct. og er et resultat af et amerikansk skattesystem, der tillader virksomheder at betale en lavere skat end den g\u00e6ngse amerikanske skatteyder. BioNTech betalte dog en h\u00f8jere skat p\u00e5 31 pct. i Tyskland, men opn\u00e5ede alligevel en profitmargen p\u00e5 77 pct. i f\u00f8rste halv\u00e5r.<\/p>\n\n\n\n<p>\u201dDet er fuldst\u00e6ndig uacceptabelt, midt i en ekstraordin\u00e6r krisesituation, at det accepteres, at virksomhederne for\u00f8ger deres indtjening ved at betale s\u00e5 lidt i skat som muligt og samtidig udnytter deres monopoler til at s\u00e6lge til h\u00f8jestbydende. Lige nu raser pandemien i mange udviklingslande, som slet ikke kan f\u00e5 vacciner nok,\u201d siger Trine Pertou Mach.<\/p>\n\n\n\n<p>Salget af boostershots til de allerede f\u00e6rdigvaccinerede i de rige lande er allerede godt i gang og vil sandsynligvis \u00f8ge indtjeningen hos medicinalselskaberne yderligere.<\/p>\n\n\n\n<p>WHO har for nylig opfordret til, at de rige lande venter med at give det tredje stik, f\u00f8rend at flere er blevet vaccineret globalt.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201dDet er fuldst\u00e6ndig sk\u00e6vt, at medicinalindustriens \u00f8konomiske interesser og patenter bliver beskyttet p\u00e5 bekostning af menneskeliv.&#8221;<\/p>\n","protected":false},"featured_media":853,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"2477,2428,1809,1672,1697,999","_relevanssi_noindex_reason":"","editor_notices":[]},"categories":[],"tags":[149,138],"class_list":["post-2863","pressemeddelelser","type-pressemeddelelser","status-publish","has-post-thumbnail","hentry","tag-covid-19","tag-inequity"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.3 (Yoast SEO v26.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner | Oxfam Denmark<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner\" \/>\n<meta property=\"og:description\" content=\"\u201dDet er fuldst\u00e6ndig sk\u00e6vt, at medicinalindustriens \u00f8konomiske interesser og patenter bliver beskyttet p\u00e5 bekostning af menneskeliv.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxfam Denmark\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T09:49:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"610\" \/>\n\t<meta property=\"og:image:height\" content=\"407\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data2\" content=\"Astrid\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/\",\"url\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/\",\"name\":\"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner | Oxfam Denmark\",\"isPartOf\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp\",\"datePublished\":\"2021-09-16T09:47:00+00:00\",\"dateModified\":\"2025-07-16T09:49:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage\",\"url\":\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp\",\"contentUrl\":\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp\",\"width\":610,\"height\":407},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/oxfam.symbiotisk.net\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pressemeddelelser\",\"item\":\"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#website\",\"url\":\"https:\/\/oxfam.symbiotisk.net\/en\/\",\"name\":\"Oxfam Denmark\",\"description\":\"We fight inequality and injustice\",\"publisher\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oxfam.symbiotisk.net\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#organization\",\"name\":\"Oxfam Denmark\",\"url\":\"https:\/\/oxfam.symbiotisk.net\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/08\/logo-en.svg\",\"contentUrl\":\"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/08\/logo-en.svg\",\"width\":141,\"height\":60,\"caption\":\"Oxfam Denmark\"},\"image\":{\"@id\":\"https:\/\/oxfam.symbiotisk.net\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner | Oxfam Denmark","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/","og_locale":"en_GB","og_type":"article","og_title":"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner","og_description":"\u201dDet er fuldst\u00e6ndig sk\u00e6vt, at medicinalindustriens \u00f8konomiske interesser og patenter bliver beskyttet p\u00e5 bekostning af menneskeliv.\"","og_url":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/","og_site_name":"Oxfam Denmark","article_modified_time":"2025-07-16T09:49:48+00:00","og_image":[{"width":610,"height":407,"url":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"3 minutes","Written by":"Astrid"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/","url":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/","name":"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner | Oxfam Denmark","isPartOf":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage"},"image":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage"},"thumbnailUrl":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp","datePublished":"2021-09-16T09:47:00+00:00","dateModified":"2025-07-16T09:49:48+00:00","breadcrumb":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#primaryimage","url":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp","contentUrl":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/05\/YXNzZXRzL294ZmFtLWRhbm1hcmstZGVmYXVsdC1iaWxsZWRlLmpwZw.webp","width":610,"height":407},{"@type":"BreadcrumbList","@id":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/medicinalvirksomheder-hoester-store-profitter-paa-covid-19-vacciner-mens-verdens-fattigste-lande-stadig-mangler-vacciner\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/oxfam.symbiotisk.net\/en\/"},{"@type":"ListItem","position":2,"name":"Pressemeddelelser","item":"https:\/\/oxfam.symbiotisk.net\/en\/pressreleases\/"},{"@type":"ListItem","position":3,"name":"Medicinalvirksomheder h\u00f8ster store profitter p\u00e5 Covid-19-vacciner, mens verdens fattigste lande stadig mangler vacciner"}]},{"@type":"WebSite","@id":"https:\/\/oxfam.symbiotisk.net\/en\/#website","url":"https:\/\/oxfam.symbiotisk.net\/en\/","name":"Oxfam Denmark","description":"We fight inequality and injustice","publisher":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oxfam.symbiotisk.net\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/oxfam.symbiotisk.net\/en\/#organization","name":"Oxfam Denmark","url":"https:\/\/oxfam.symbiotisk.net\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/oxfam.symbiotisk.net\/en\/#\/schema\/logo\/image\/","url":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/08\/logo-en.svg","contentUrl":"https:\/\/oxfam.symbiotisk.net\/en\/wp-content\/uploads\/sites\/2\/2025\/08\/logo-en.svg","width":141,"height":60,"caption":"Oxfam Denmark"},"image":{"@id":"https:\/\/oxfam.symbiotisk.net\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/pressemeddelelser\/2863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/pressemeddelelser"}],"about":[{"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/types\/pressemeddelelser"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/media\/853"}],"wp:attachment":[{"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/media?parent=2863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/categories?post=2863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oxfam.symbiotisk.net\/en\/wp-json\/wp\/v2\/tags?post=2863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}